Wegovy, for example, is a well-established semaglutide injection shown to facilitate remarkable weight reduction
Why This Might Be Happening During GLP-1 Related Weight Loss
Patients with MDD exhibit KP dysregulation, often marked by an overproduction of quinolinic acid, an N-Methyl-D-aspartic acid receptor (NMDAR) agonist that drives excitotoxicity, alongside reduced production of kynurenic acid, an NMDAR antagonist that protects from excitotoxicity and has anti-inflammatory effects
Cell Host & Microbe DOI:10.1016/j.chom.2026.05.003 Abstract Microbiota-driven gutbrain signaling underlies antidepressant effects of a GLP-1 analog Despite widespread clinical use of glucagon-like peptide-1 receptor (GLP-1R) agonists for metabolic disease, their neuropsychiatric effects remain poorly understood and controversial
Eden serves 46 states: not available in Arkansas, Louisiana, Mississippi, and New Mexico
This does not mean every patient has to give up alcohol